Kala Bio Introduces AI Infrastructure Platform 'Researgency' for Biotech Sector
Kala Bio, a Massachusetts-based biopharmaceutical firm, launched 'Researgency', an on-premises AI platform for biotech. Developed with Younet AI, it facilitates secure storage of proprietary biological data. The firm secured an exclusive 12-month license for Researgency and plans to pilot it internally before offering it as a subscription service. This move aims to address the need for data sovereignty in biotech, as the industry transitions from centralized AI solutions.
Theia Market Signal Identification - AI Assisted
Kala Bio has launched 'Researgency', an on-premises AI infrastructure platform tailored for the biotech industry. The platform, developed in collaboration with Younet AI, allows firms to securely store sensitive biological data, addressing industry privacy concerns.
Kala Bio has obtained a 12-month exclusive license for Researgency, with plans to pilot the platform internally and subsequently offer it as a subscription service. This initiative aims to provide a data-sovereign solution that contrasts with centralized AI platforms, responding to the growing demand for secure AI deployments in regulated sectors. The biotech industry's AI spending is projected to reach $25 billion by 2030, highlighting the potential market for such infrastructure.
Comments